The stock's fall snapped a seven-day winning streak.

The new campaign stars former NFL quarterback Alex Smith, whose leg injury during a 2018 game led to a case of ...

We expect Vertex Pharmaceuticals Incorporated VRTX to surpass expectations when it reports first-quarter 2025 results on May ...

Retired NFL quarterback Alex Smith is helping others through the 'taboo' of pain after nearly dying from a leg injury in 2018 ...

Shares of Vertex Pharmaceuticals Inc. VRTX rallied 1.19% to $509.50 Wednesday, on what proved to be an all-around positive ...

FOX Sports' Joel Klatt joins Colin Cowherd to dive into what led to Shedeur Sanders dropping to the fifth round and how he ...

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...

Vertex Pharmaceuticals (VRTX) shares have climbed 22.3% year-to-date, significantly outpacing the S&P 500 and broader healthcare sector ...

The market expects Vertex Pharmaceuticals (VRTX) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known ...

Vertex Pharmaceuticals (VRTX) reachead $509.47 at the closing of the latest trading day, reflecting a +1.19% change compared to its last close. Looking beyond Wall Street's top -and-bottom-line ...